Medtronic PLC vs Williams Companies Inc — how do they compare? Medtronic PLC trades at $82.53 (market cap $106.61B), while Williams Companies Inc trades at $73.67 (market cap $90.70B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | WMB | |
|---|---|---|
Market Cap | $106.61B | $90.70B |
Sector | Health | Energy |
52-Week High | $105.35 | $79.40 |
52-Week Low | $73.75 | $56.51 |
Enterprise Value | $125.36B | $120.08B |
Dividend Yield | 3.46% | 2.83% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
WMB trades at $74.57, up 1.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $11.95B in 2025 with a net income margin of 23.4% and recently secured a $5.34 billion Blackstone-led investment for power projects. Analyst consensus is strongly bullish with a $86.00 price target and 79% buy ratings.
The outlook is supported by strategic investments in energy infrastructure and stable cash flows, but risks include high debt levels and sensitivity to natural gas prices. The stock offers a dividend yield and growth potential from LNG expansion, though recent earnings misses warrant monitoring execution on new projects.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →